The July 2026 advisory review could reopen compounding pathways for peptides previously curtailed in 2023 over immunogenicity ...
A US Food and Drug Administration (FDA) official acknowledged significant regulatory hurdles in the development of products ...
AST and Marchesini Group, leaders in the design and manufacture of equipment for the pharmaceutical sector, will take part in this year's INTERPHEX event, scheduled from April 21 to 23. Following the ...
Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 ...
While FDA’s draft guidance may alleviate some of the pressures when biosimilar developers, there are still other significant ...
Company is among the first in China's drug-device combination products sector to obtain this certification, delivering ...
ReNerve Limited (ASX: ReNerve), an Australian biotechnology company developing innovative products for peripheral nerve ...
The Career Services Centre of the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, in collaboration with ...
The Career Services Centre of the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, in collaboration with ...
When it comes to recipes being changed, “I think it’s more than just candy. I think it’s all foods,” says Dr. Richard Hartel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results